However, the inhibition of mTOR has been observed to cause multiple side effects, including thrombocytopenia, as mTOR is a crucial signalling molecule in various pathways [203,204] and it has been alleged that studies thus far on rapamycin’s potential as a senomorphic have been carried out at sub-optimal doses. The gene discussed is MTOR; the disease is Thrombocytopenia.